Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism MLLT1 modulators(MLLT1 super elongation complex subunit modulators), MLLT3 inhibitors(MLLT3 super elongation complex subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H21N3O4 |
InChIKeyIXWUILRSNIQHDM-QGZVFWFLSA-N |
CAS Registry2675452-91-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diagnostic agents | Preclinical | US | 01 Jan 2024 |